Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Pacemaker Co. Seeks Clarity on Qui Tam Publicity Test No Photo Available

Dan McKay

A medical device company is asking the U.S. Supreme Court to clarify the False Claims Act's public disclosure bar. To succeed, the com... (more story)

Healthcare Deals This Week: Novartis, Sanofi, Gilead No Photo Available

Yeji Jesse Lee

Alphabet's mega-round and major agreements in the T-cell engager space. Law360 breaks down the big deals from the past week.

Utah Hospitals To Track Violence As States Step Up Reporting No Photo Available

Dan McKay

Under a new law, Utah hospitals will join a national effort to better understand the risks facing healthcare workers.